We are live on
!
Find out more
RC
Rangeley Capital Portfolio holdings
AUM
$109M
Turnover
49.06%
1-Year Est. Return
97.13%
This Fund
S&P 500
This Quarter
Est. Return
-3.19%
1 Year Est. Return
+97.13%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$103M
AUM Growth
-$17.5M
(-15%)
Cap. Flow
-$8.34M
Cap. Flow
% of AUM
-8.11%
Top 10 Holdings %
Top 10 Hldgs %
35.28%
Holding
169
New
46
Increased
35
Reduced
35
Closed
32
Avg Time Held Equity + Options
0.4
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.4
years
Avg Time Held Equity only
0.4
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Driven Brands
DRVN
|
+$8.81M |
| 2 |
Revolution Medicines
RVMD
|
+$6.74M |
| 3 |
Icon
ICLR
|
+$2.42M |
| 4 |
TripAdvisor
TRIP
|
+$2.21M |
| 5 |
Elme Communities
ELME
|
+$2.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Golden Entertainment
GDEN
|
+$5.71M |
| 2 |
Calumet Specialty Products
CLMT
|
+$5.34M |
| 3 |
Warner Bros
WBD
|
+$4.62M |
| 4 |
RNAM
Avidity Biosciences
RNAM
|
+$3.9M |
| 5 |
Repare Therapeutics
RPTX
|
+$3.35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.22% |
| 2 | Consumer Discretionary | 17.78% |
| 3 | Miscellaneous | 13.22% |
| 4 | Real Estate | 12.14% |
| 5 | Financials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Driven Brands
DRVN
$1.97B
| $7.89M | 7.66% |
+625,500
| New | +$8.81M |
2026 Q1
0 quarters
|
|
2
PUT
Liquidia Corp
LQDA
$3.07B
| $5.66M | 5.5% |
+150,000
| New | +$5.57M |
2026 Q1
0 quarters
|
|
3
Prothena Corp
PRTA
$429M
| $4.37M | 4.24% |
449,460
-75,140
| -14% | -$689K |
2025 Q2
3 quarters
|
|
4
Seaport Entertainment Group
SEG
$292M
| $3.3M | 3.2% |
153,517
| – | – |
2024 Q4
5 quarters
|
|
|
5
CALL
Liquidia Corp
LQDA
$3.07B
| $2.83M | 2.75% |
+75,000
| New | +$2.78M |
2026 Q1
0 quarters
|
|
6
Grindr
GRND
$2.45B
| $2.83M | 2.75% |
234,000
+22,000
| +10% | +$259K |
2025 Q4
1 quarter
|
|
7
Delek US
DK
$4.69B
| $2.7M | 2.63% |
60,000
-42,000
| -41% | -$1.5M |
2024 Q4
5 quarters
|
|
8
Arvinas
ARVN
$456M
| $2.37M | 2.31% |
223,990
-171,810
| -43% | -$2.13M |
2025 Q1
4 quarters
|
|
9
Arbutus Biopharma
ABUS
$836M
| $2.25M | 2.19% |
500,000
-340,000
| -40% | -$1.49M |
2024 Q4
5 quarters
|
|
10
EchoStar
ECHO
$24.8B
| $2.11M | 2.05% |
18,000
-6,000
| -25% | -$689K |
2025 Q3
2 quarters
|
|
11
DELISTED
Leggett & Platt
LEG
| $2.1M | 2.04% |
213,000
+77,070
| +57% | +$880K |
2025 Q4
1 quarter
|
|
12
Star Holdings Shares of Beneficial Interest
STHO
$93M
| $2.07M | 2.02% |
274,072
+86,972
| +46% | +$716K |
2024 Q4
5 quarters
|
|
13
Full House Resorts
FLL
$39.9M
| $2.06M | 2% |
915,578
+19,578
| +2% | +$47.1K |
2024 Q4
5 quarters
|
|
|
14
TripAdvisor
TRIP
$1.09B
| $2.03M | 1.97% |
+190,000
| New | +$2.21M |
2026 Q1
0 quarters
|
|
15
Orion Office REIT
ONL
$118M
| $1.97M | 1.91% |
+915,000
| New | +$2.12M |
2026 Q1
0 quarters
|
|
|
16
Icon
ICLR
$13.1B
| $1.96M | 1.9% |
+17,700
| New | +$2.42M |
2026 Q1
0 quarters
|
|
|
17
Calumet Specialty Products
CLMT
$5.08B
| $1.9M | 1.85% |
53,000
-206,300
| -80% | -$5.34M |
2024 Q4
5 quarters
|
|
18
Green Dot
GDOT
$695M
| $1.83M | 1.77% |
+162,732
| New | +$1.92M |
2026 Q1
0 quarters
|
|
19
DELISTED
Kezar Life Sciences
KZR
| $1.8M | 1.75% |
243,073
+157,147
| +183% | +$1.02M |
2025 Q4
1 quarter
|
|
20
Janux Therapeutics
JANX
$1.01B
| $1.7M | 1.65% |
122,500
+97,086
| +382% | +$1.33M |
2025 Q4
1 quarter
|
|
21
DELISTED
Theravance Biopharma
TBPH
| $1.67M | 1.62% |
+103,000
| New | +$1.82M |
2026 Q1
0 quarters
|
|
22
DELISTED
Mister Car Wash
MCW
| $1.54M | 1.49% |
+220,500
| New | +$1.42M |
2026 Q1
0 quarters
|
|
23
Brighthouse Financial
BHF
$2.75B
| $1.5M | 1.45% |
25,000
| – | – |
2025 Q3
2 quarters
|
|
|
24
CALL
DELISTED
Warner Bros
WBD
| $1.46M | 1.42% |
53,300
-5,300
| -9% | -$148K |
2025 Q4
1 quarter
|
|
25
ZIM Integrated Shipping Services
ZIM
$3.52B
| $1.45M | 1.41% |
55,000
+13,948
| +34% | +$347K |
2025 Q4
1 quarter
|
|
Similar funds
GCM
SSCM
RCM
BWM
AC
SCA
SPM
S2L
Rangeley Capital's Q1 2026 Portfolio in Review
As of Q1 2026, Rangeley Capital held 169 positions worth $103M, down 15% from $120M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Rangeley Capital withdrew a net $8.34M in Q1 2026, closing 32 positions and reducing 35 holdings. Its most notable exit was Golden Entertainment, an estimated $5.71M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Miscellaneous.
Against the trend, Rangeley Capital opened a new position in Driven Brands worth $7.89M.
- Rangeley Capital's largest Q1 2026 buy was Driven Brands: 625,500 shares worth $7.89M.
- Rangeley Capital added most to Janux Therapeutics in Q1 2026, an estimated $1.33M increase.
- Rangeley Capital's biggest Q1 2026 reduction was Calumet Specialty Products, cutting an estimated $5.34M.
- Rangeley Capital fully exited Golden Entertainment in Q1 2026, selling an estimated $5.71M.
- Rangeley Capital's ten largest holdings make up 35% of its $103M portfolio in Q1 2026.
- Rangeley Capital opened 46 new positions and closed 32 in Q1 2026.
- Rangeley Capital's portfolio value fell 15% quarter-over-quarter to $103M.
Based on Rangeley Capital's 13F filing for Q1 2026, filed 15 May 2026.